Hosted on MSN
With a New Take on an Old Schizophrenia Drug, LB Pharma Prepares IPO to Fund Phase 3 Test
Many drugs are available for schizophrenia, but insufficient efficacy and intolerable side effects leave an unmet need that biotech companies are still trying to fill. LB Pharmaceuticals is not ...
As Teva proceeds down the more muted growth path that it telegraphed early this year, the generics and innovative medicines ...
Hello everybody, and welcome to the Q2 2026 Teva Pharmaceutical Industries Earnings Conference Call. My name is Elliot. I'll be coordinating your call today. [Operator Instructions] I would now like ...
Company plans to request an FDA meeting following the interim readout to discuss the regulatory pathway for a New Drug Application (NDA) for tafenoquine in babesiosis WASHINGTON, July 29, 2026 (GLOBE ...
Daily Mail on MSN
Heavy smoker died after giving up cigarettes due to reaction with medication, inquest hears
Jack Burton, 29, was prescribed anti-psychotic medication to treat his schizophrenia, but smoking cigarettes lessened the ...
A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy ...
Tirzepatide works the same way. It is the active ingredient in both Mounjaro and Zepbound, both made by Eli Lilly. Mounjaro ...
The FDA issued a nationwide Class II recall of levothyroxine, a common thyroid medication, due to concerns over potency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results